Intuitive Surgical Inc. (ISRG): Today's Featured Health Care Laggard

Intuitive Surgical ( ISRG) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day down 0.3%. By the end of trading, Intuitive Surgical fell $80.78 (-16.1%) to $419.30 on heavy volume. Throughout the day, 5,464,574 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 330,500 shares. The stock ranged in price between $406.69-$429.88 after having opened the day at $428.00 as compared to the previous trading day's close of $500.08. Other companies within the Health Care sector that declined today were: Biota Pharmaceuticals ( BOTA), down 70.1%, Pingtan Marine Enterprise ( PME), down 65.1%, Mast Therapeutics ( MSTX), down 38.6% and Oramed Pharmaceuticals ( ORMP), down 13.9%.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Intuitive Surgical has a market cap of $20.2 billion and is part of the health services industry. Shares are up 2.8% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Intuitive Surgical a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself.

On the positive front, Inovio Pharmaceuticals ( INO), up 24.2%, CytRx Corporation ( CYTR), up 20.9%, Prosensa ( RNA), up 19.6% and Redhill Biopharma ( RDHL), up 18.3% , were all gainers within the health care sector with Bristol-Myers Squibb Company ( BMY) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

The Method Behind My Investing Madness: Cramer's 'Mad Money' Recap (Wed 9/6/17)

Novartis AG, Sirius XM Radio, Coupa Software: 'Mad Money' Lightning Round

August's Inexplicable Selloffs Are Here: Cramer's 'Mad Money' Recap (8/17/17)

Blue Apron, Philip Morris, Honeywell, Becton Dickinson: 'Mad Money' Lightning Round